Almac

Almac has extensive facilities throughout the UK and US and has approximately 2,000 highly skilled employees. The company has formed partnerships with all major global pharma and biotech companies and provide contract development services from R&D to supply of finished product.

We offer extensive integrated development services ranging from:

• Commercial scale manufacture and distribution;
• Manufacturing/blinding, packaging, randomised labelling, distribution of clinical supplies;
• Formulation development of tablets and capsules;
• Comprehensive analytical services;
• EU import testing and QP release for clinical and commercial product.
• Clinical trial technology solutions based on IVRS, Web and EDC;
• Route design and synthesis of APIs (including potent, peptide and chiral compounds);
• Gene expression profiling and bioinformatics;

A recent investment of $10 million has enabled us to open a new, state-of-the-art dedicated 10,500 sq ft formulation facility with high containment capabilities, providing extended formulation development services from pre-clinical though to pilot scale.

Almac Pharma Services: Formulation development through to commercial scale manufacture, packaging, QP release and distribution of finished product.

Almac Clinical Services: Global clinical supplies management, including manufacture and blinding, packaging, labelling, EU qualified person release and distribution.

Almac Sciences: Innovative chemistry solutions and products connection drug discovery and development with powerful manufacturing.

Almac Clinical Technologies: Integrated technology and service solutions that increase the quality and efficiency of the clinical trial process (IVRS/Web/EDC/eDiary).

Almac Diagnostics: Generation of novel diagnostic products to improve patient management. Accredited gene expression profiling service based on standard and proprietary Disease Specific Arrays (DSATM).